Nonoxidative protein glycation is implicated in familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation

Acta Neuropathologica

Volumn 100, Issue 3, 2000, Pages 275-284

  Shibata, Noriyuki ^a   Nagai, Ryoji ^b   Miyata, Satoshi ^c   Jono, Tadashi ^b   Horiuchi, Seikoh ^b   Hirano, Asao ^d   Kato, Shinsuke ^e   Sasaki, Shoichi ^a   Asayama, Kohtaro ^f   Kobayashi, Makio ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^c KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d MONTEFIORE MEDICAL CENTER   (United States)

^e TOTTORI UNIVERSITY   (Japan)

^f UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Amyotrophic lateral sclerosis; Imidazolone; N( ) carboxymethyl lysine; Pyrraline; Superoxide dismutase

Indexed keywords

4 HYDROXYNONENAL; DEOXYGUANOSINE DERIVATIVE; IMIDAZOLE DERIVATIVE; PENTOSIDINE; PROTEIN; PYRRALINE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; FEMALE; GENE MUTATION; GLIA CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEWY BODY; LIPID PEROXIDATION; MALE; MOTONEURON; NERVE CELL; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; SPINAL CORD;

EID: 0033947469     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004019900173     Document Type: Article

References (79)

1. ε-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. J Biol Chem 261: 4889-4894
2. ε(Carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem J 324: 565-570
3. Araki N, Ueno N, Chakrabarti B, Morino Y, Horiuchi S (1992) Immunohistochemical evidence for the presence of advanced glycation end products in human lens proteins and its positive correlation with aging. J Biol Chem 267: 10211-10214
4. Asayama K, Janco RL, Burr IM (1985) Selective induction of manganous superoxide dismutase in human monocytes. Am J Physiol 249: C393-C397
5. Beckman JS, Carson M, Smith CD, Koppenol WH (1993) ALS, SOD, and peroxynitrite. Nature 364: 584
6. Bowling AC, Schulz JB, Brown RH Jr, Beal MF (1993) Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J Neurochem 61: 2322-2325
7. Brennan M (1989) Changes in solubility, non-enzymatic glycation, and fluorescence of collagen in tail tendons from diabetic rats. J Biol Chem 264: 20947-20952
8. Brown RH Jr (1998) SOD1 aggregates in ALS: cause, correlate or consequence? Nat Med 4: 1362-1364
9. Bruijn LI, Becher MW, Lee MK, Anderson KL, Jenkins NA, Copeland NG, Sisodia SS, Rothstein JD, Borchelt DR, Price DL, Cleveland DW (1997) ALS-imked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18: 327-338
10. Bruijn LI, Houseweart MK, Kato S, Anderson KL, Anderson SD, Ohama E, Reasume AG, Scott RW, Cleveland DW (1998) Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 281: 1851-1854
11. Carri MT, Battistoni A, Polizio F, Desideri A, Rotilio G (1994) Impaired copper binding by the H46R mutant of human Cu,Zn superoxide dismutase, involved in amyotrophic lateral sclerosis. FEBS Lett 356: 314-316
12. 2+ concentration in transfected neuroblastoma SH-SY5Y cells. FEBS Lett 414: 365-368
13. Castellani R, Smith MA, Richey PL, Perry G (1996) Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease. Brain Res 737: 195-200
14. Durham HD, Roy J, Dong L, Figlewicz DA (1997) Aggregation of mutant Cu/Zn superoxide dismutase proteins in a culture model of ALS. J Neuropathol Exp Neurol 56: 523-530
15. Esterbauer H, Schaur JS, Zollner H (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11: 81-128
16. Ferrante RJ, Browne SE, Shinobu LA, Bowling AC, Baik MJ, MacGarvey U, Kowall NW, Brown RH Jr, Beat MF (1997) Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochem 69: 2064-2074
17. Fridovich I (1986) Superoxide dismutases. Adv Enzymol Relat Areas Mol Biol 58: 61-97
18. ε-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J Biol Chem 271: 9982-9986
19. Fujita K, Yamauchi M, Shibayama K, Ando M, Honda M, Nagata Y (1996) Decreased cytochrome c oxidase activity but unchanged superoxide dismutase and glutathione peroxidase activities in the spinal cords of patients with amyotrophic lateral sclerosis. J Neurosci Res 45: 276-281
20. Glomb MA, Monnier VM (1995) Mechanism of protein modification by glyoxal and glycoaldehyde, reactive intermediates of the Maillard reaction. J Biol Chem 270: 10017-10026
21. Hayase F, Nagaraj RH, Miyata S, Njoroge FG, Monnier VM (1989) Aging of proteins: immunological detection of a glucose-derived pyrrole formed during Maillard reaction in vivo. J Biol Chem 263: 3758-3764
22. Hayase F, Shibuya T, Sato J, Yamamoto M (1996) Effects of oxygen and transition metals on the advanced Maillard reaction of proteins with glucose. Biosci Biotech Biochem 60: 1820-1825
23. Hirano A (1996) Neuropathology of ALS: an overview. Neurology 47 [Suppl 2]: S63-S66
24. Horiuchi S, Araki N, Morino Y (1991) Immunochemical approach to characterize advanced glycation end products of the Maillard reaction: evidence for the presence of a common structure. J Biol Chem 266: 7329-7332
25. Horiuchi S, Araki N, Nakamura K, Ikeda K, Fukunaga Y, Ienaga K (1996) A new fluorescent crosslinker (AGE-X1) isolated from AGE-lysine derivatives. Diabetes 45 [Suppl 2]: 186A
26. ε-(Carboxymethyl)lysine protein adduct is a major immunochamical epitope in protein modified with advanced glycation end products of the Maillard reaction. Biochemistry 35: 8075-8083
27. Ince PG, Shaw PJ, Candy JM, Mantle D, Tandon L, Ehmann WD, Markesbery WR (1994) Iron, selenium and glutathione peroxidase activity are elevated in sporadic motor neuron disease. Neurosci Lett 182: 87-90
28. Kasai H, Nishimura S (1984) Hydroxylation of deoxyguanosine at the C-8 position by ascrobic acid and other reducing agents. Nucleic Acids Res 12: 2137-2145
29. Kato S, Hayashi H, Nakashima K, Nanba E, Kato M, Hirano A, Nakano I, Asayama K, Ohama E (1997) Pathological characterization of astrocytic hyaline inclusions in familial amyotrophic lateral sclerosis. Am J Pathol 151: 611-620
30. Kato S, Horiuchi S, Nakashima K, Hirano A, Shibata N, Nakano I, Saito M, Kato M, Asayama K, Ohama E (1999) Astrocytic hyaline inclusions contain advanced glycation endproducts in familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation: immunohistochemical and immunoelectron microscopic analyses. Acta Neuropathol 97: 260-266
31. Kimura T, Ikeda K, Takamatsu J, Miyata T, Sobue G, Miyakawa T, Horiuchi S (1996) Identification of advanced glycation end products of the Maillard reaction in Pick's disease. Neurosci Lett 219: 95-98
32. Kirstein M, Brett J, Radoff S, Ogawa S, Stern D, Vlassara H (1990) Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proc Natl Acad Sci USA 87: 9010-9014
33. Konishi Y, Hayase F, Kato H (1994) Novel imidazolone compound formed by the advanced Maillard reaction of 3-deoxyglucosone and arginine residues in proteins. Biosci Biotech Biochem 58: 1953-1955
34. Kume S, Takeya M, Mori T, Araki N, Suzuki H, Horiuchi S, Kodama T, Miyauchi Y, Takahashi K (1995) Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody. Am J Pathol 147: 654-667
35. Kusaka H, Hirano A (1999) Cytopathology of the motor neuron. In: Younger DS (ed) Motor disorders. Lippincott & Wilkins, Philadelphia, pp 93-101
36. Liochev SI, Chen LL, Hallewell RA, Fridovich I (1997) Superoxide-dependent peroxidase activity of H48Q: a superoxide dismutase variant associated with familial amyotrophic lateral sclerosis. Arch Biochem Biophys 346: 263-268
37. 2. Arch Biochem Biophys 352: 237-239
38. Loidl-Stahlhofen A, Hannemann K, Spiteller G (1995) Detection of short-chain α-hydroxyaldehydic compounds as pentafluorobenzyloxime derivatives in bovine liver. Chem Phys Lipids 77: 113-119
39. Marklund SL, Andersen PM, Forsgren L, Nilsson P, Ohlsson P-I, Wikander G, Oberg A (1997) Normal binding and reactivity of copper in mutant superoxide dismutase isolated from amyotrophic lateral sclerosis patients. J Neurochem 69: 675-681
40. Miyata S, Monnier V (1992) Immunohistochemical detection of advanced glycosylation end products in diabetic tissue using monoclonal antibody to pyrraline. J Clin Invest 89: 1102-1112
41. ε-(carboxymethyl)lysine, one of the glycoxidation products of the Maillard reaction. J Invest Dermatol 108: 797-802
42. Murayama S, Namba E, Nishiyama K, Kitamura Y, Morita T, Nakashima K, IshidaT, Mizutani T, Kanazawa I (1997) Molecular pathological studies of familial amyotrophic lateral sclerosis. Neuropathology 17 [Suppl]: 219A
43. ε-(carboxymethyl)lysine formation from Amadori product. Biochem Biophys Res Commun 234: 167-172
44. Nakamura K, Hasegawa T, Fukunaga Y, Ienaga K (1992) Crosslines A and B as candidates for the fluorophores in age- and diabetes-related cross-linked proteins, and their diacetates produced by Maillard reaction of α-N-acetyl-L-lysine with D-glucose. J Chem Soc Chem Commun 14: 992-994
45. Nakamura K, Nakazawa Y, Ienaga K (1997) Acid-stable fluorescent advanced glycation end products: vesperlysines A, B, and C are formed as crosslinked products in the Maillard reaction between lysine or proteins with glucose. Biochem Biophys Res Commun 232: 227-230
46. ε-(carboxymethyl)lysine in dialysis-related amyloidosis. Kidney Int 50: 1303-1309
47. Niwa T, Katsuzaki T, Miyazaki S, Miyazaki T, Ishizaki Y, Hayase F, Tatemichi N, Takei Y ( 1997) Immunohistochemical detection of imidazolone, a novel advanced glycation end products, in kidneys and aortas of diabetic patients. J Clin Invest 99: 1272-1280
48. Pedersen WA, Fu W, Keller JN, Markesbery WR, Appel S, Smith RG, Kasarkis E, Mattson MP (1998) Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Ann Neurol 44: 819-824
49. Pedersen WA, Cashman NR, Mattson MP (1999) The lipid peroxidation product 4-hydroxynonenal impairs glutamate and glucose transport and choline acetyltransferase activity in NSC-19 motor neuron cells. Exp Neurol 155: 1-10
50. Przedborski S, Donaldson D, Jakowec M, Kish SJ, Guttman M, Rosoklija G. Hays AP (1996) Brain superoxide dismutase, catalase, and glutathione peroxidase activities in amyotrophic lateral sclerosis. Ann Neurol 39: 158-165
51. Rabizadeh S, Gralla EB, Borchelt DR, Gwinn R, Valentine JS, Sisodia S, Wong P, Lee M, Hahn H, Bredesen DE (1995) Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells. Proc Natl Acad Sci USA 92: 3024-3028
52. Rosen DR, Bowling AC, Patterson D, Usdin TB, Sapp P, Mezey E, McKenna-Yasek D, O'Regan J, Rahmani Z, Ferrante RJ, Brownstein MJ, Kowall NW, Beal MF, Horvitz HR, Brown RH Jr (1994) A frequent ala 4 to val superoxide dismutase-1 mutation is associated with a rapidly progressive familial amyotrophic lateral sclerosis. Hum Mol Genet 3: 981-987
53. Schmidt AM, Hori O, Chen JX, Li JF, Crandall J, Zhang J, Cao R, Yan SD, Brett J, Stern D (1995) Advanced glycation end-products interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. J Clin Invest 96: 1395-1403
54. Sell DR, Monnier VM (1989) Structure elucidation of a senescence cross-link from human extracellular matrix. J Biol Chem 264: 21597-21602
55. Shaw PJ, Chinnery RM, Thagesen H, Borthwick GM, Ince PG (1997) Immunocytochemical study of the distribution of the tree radical scavenging enzymes Cu/Zn superoxide dismutase (SOD1): Mn superoxide dismutase (Mn SOD) and catalase in the normal human spinal cord and in motor neuron disease. J Neurol Sci 147: 115-125
56. Shibata N, Hirano A, Kobayashi M, Asayama K, Umahara T, Komori T, Ikemoto A (1993) Immunohistochemical demonstration of Cu/Zn superoxide dismutase in the spinal cord of patients with familial amyotrophic lateral sclerosis. Acta Histochem Cytochem 26: 619-622
57. Shibata N, Hirano A, Kobayashi M, Siddique T, Deng H-X, Hung W-Y, Kato T, Asayama K (1996) Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. J Neuropathol Exp Neurol 55: 481-490
58. Shibata N, Asayama K, Hirano A, Kobayashi M (1996) Immunohistochemical study on superoxide dismulases in spinal cords from autopsied patients with amyotrophic lateral sclerosis. Dev Neurosci 18: 492-498
59. Shibata N, Hirano A, Kobayashi M, Dal Canto MC, Gurney ME. Komori T, Umahara T, Asayama K (1998) Presence of Cu/ Zn superoxide dismutase (SOD) immunoreactivity in neuronal hyaline inclusions in spinal cords from mice carrying a transgene for Gly93Ala mutant human Cu/Zn SOD. Acta Neuropathol 95: 136-142
60. Shibata N, Hirano A, Kato S, Nagai R, Horiuchi S, Komori T, Umahara T, Asayama K, Kobayashi M (1999) Advanced glycation endproducts are deposited in neuronal hyalin inclusions: a study on familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation. Acta Neuropathol 97: 240-246
61. Shibata N, Kobayashi M, Hirano A, Asayama K, Horiuchi S, Dal Canto MC, Gurney ME (1999) Morphological aspects of superoxidc dismutase-1 mutation in amyotrophic lateral sclerosis. Acta Histochem Cytochem 32: 17-30
62. 2. Proc Natl Acad Sci USA 95: 6675-6680
63. Smith MA, Taneda S, Richey PL, Miyata S, Van SD, Stern D, Sayre LM, Monnier VM, Perry G (1994) Advanced glycation end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci USA 91: 5710-5714
64. Suzuki H, Kurihara Y, Takeya M, et al (1997) A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 386: 292-296
65. Takahashi H (1995) Familial amyotrophic lateral sclerosis with or without mutation of the Cu/Zn superoxide dismutase gene. Brain Nerve 47: 535-541
66. Takahashi S, Hirose M, Tamano S, Ozaki M, Orita S-I, Ito T, Takeuchi M, Ochi H, Fukada S, Kasai H, Shirai T (1998) Immunohistochemical detection of 8-hydroxy-2′-deoxyguanosine in paraffin-embedded sections of rat liver after carbon tetrachloride treatment. Toxicol Pathol 26: 247-252
67. Takeda A, Yasuda T, Miyata T, Goto Y, Wakai M, Watanabe M, Yasuda Y, Horie K, Inagaki T, Doyu M, Maeda K, Sobue G (1998) Advanced glycation end products co-localized with astrocytes and microglial cells in Alzheimer's disease brain. Acta Neuropathol 95: 555-558
68. Takehisa Y, Ishizu H, Ujike H, Haraguchi T, Terada S, Nishinaka T. Tanaka Y, Tanabe Y, Kuroda S, Nobukuni K, Namba R, Hayabara T (1999) Familial amyotrophic lateral sclerosis with the L126S mutation in the copper/zinc superoxide dismutase (SOD1) gene. Neuropathology 19: A63
69. Toyokuni S, Miyake N, Hiai H, Hagiwara M, Kawakishi S, Osawa T, Uchida K (1995) The monoclonal antibody specific for the 4-hydroxy-2-nonenal histidine adduct. FEBS Lett 359: 189-191
70. Toyokuni S, Tanaka T, Hattori Y, Nishiyama Y, Yoshida A, Uchida K, Hiai H, Ochi H, Osawa T (1997) Quantitive immunohistochemical determination of 8-hydroxy-2′-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitriloacetate-induced renal carcinogenesis model. Lab Invest 76: 365-374
71. Uchida K, Kanematsu M, Morimitsu Y, Osawa T, Noguchi N, Niki E (1998) Acrolein is a product of lipid peroxidation reaction. J Biol Chem 273: 16058-16066
72. Uchida K, Kanematsu M, Sakai K, Matsuda T, Hattori N, Mizuno Y, Suzuki D, Miyata T, Noguchi N, Niki E, Osawa T (1998) Protein-bound acrolein: potential markers for oxidative stress. Proc Natl Acad Sci USA 95: 4882-4887
73. Vitek MP, Bhattacharya K, Glendening JM, Stopa E, Vlassara H, Bucala R, Manogue K, Cerami A (1994) Advanced glycation end products contribute to amyoloidosis in Alzheimer disease. Proc Natl Acad Sci USA 91: 4766-4770
74. Vlassara H, Brownlee M, Manogue KR, Dinarello CA, Pasagian A (1988) Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. Science 240: 1546-1548
75. Vlassara H, Bucala R, Striker L (1994) Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 70: 138-151
76. Wells-Knecht KJ, Zyzak DV, Litchfield JE, Thorpe SR, Baynes JW (1995) Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. Biochemistry 34: 3702-3709
77. Wiedau-Pazos M, Goto JJ, Rabizadeh S, Gralla EB, Roe JA, Lee MK, Valentine JS, Bredesen DE (1996) Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 271: 515-518
78. Yan S-D, Chen X, Schmidt AM, Brett J, Godman G, Zou Y-S, Scott CW, Caputo C, Frappier T, Smith MA, Perry G, Yen S-H, Stern D (1994) Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. Proc Natl Acad Sci USA 91: 7787-7791
79. Yan SD, Zhu H, Fu J, Yan SF, Roher A, Tourtellotte WW, Rajavashisth T, Chen X, Godman GC, Stern D, Schmidt AM (1997) Amyloid-β peptide - receptor for advanced glycation endproduct stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc Natl Acad Sci USA 94: 5296-5301